Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656550 · ClinicalTrials.gov registry record · NA
Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility
A NA study of Absolute Uterine Infertility, sponsored by Baylor Research Institute.
- Active
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT02656550: Active NA study of Absolute Uterine Infertility, sponsored by Baylor Research Institute.
NCT02656550 is a NA study of Absolute Uterine Infertility that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02656550, a NA study of Absolute Uterine Infertility, is active but no longer recruiting, sponsored by Baylor Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate the treatment of absolute uterine infertility (AUI) due to congenital or surgical absence of a uterus or presence of a nonfunctioning uterus. The investigators will follow a model based on a Swedish study to enroll 20 women with functioning ovaries and successfully transplant the uterus from either a living or cadaveric donor, with the goal of live birth after transplantation.
Primary Outcome
Full term birth by cesarean section.
Conditions Studied
Interventions
- PROCEDURE Uterine Transplant
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-11-11 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT02656550 still lists
NCT02656550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Absolute Uterine Infertility appearing as the primary indexed condition, and to 1 intervention - of which Uterine Transplant is the first listed.
NCT02656550 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02656550 about?
NCT02656550 is a clinical study titled "Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility". This study aims to investigate the treatment of absolute uterine infertility (AUI) due to congenital or surgical absence of a uterus or presence of a nonfunctioning uterus. The investigators will follow a model based on a Swedish study to enroll 20 women with functioning ovaries and successfully tra...
What is the current status of trial NCT02656550?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2015-11-11. Estimated completion is 2026-11.
What conditions does trial NCT02656550 study?
This clinical trial studies the following conditions: Absolute Uterine Infertility.
What interventions are being tested in trial NCT02656550?
The interventions under investigation include: Uterine Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT02656550?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02656550 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02656550's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI